Different Risk Factor Profiles for Ischemic and Hemorrhagic Stroke in Type 1 Diabetes Mellitus
Stefanie Hägg(Helsinki University Hospital), Per‐Henrik Groop(University of Helsinki), Ron Liebkind(Institute of Genetics), Carol Forsblom(University of Helsinki), Markku Saraheimo(Helsinki University Hospital), Daniel Gordin(Helsinki University Hospital), Lena M. Thorn(University of Helsinki), Jukka Putaala(University of Helsinki), Nina Tolonen(University of Helsinki), Turgut Tatlisumak(University of Gothenburg), Johan Wadén(Helsinki University Hospital)
Cited by 54
Related Papers
The Presence and Severity of Chronic Kidney Disease Predicts All-Cause Mortality in Type 1 Diabetes
|Diabetes|2009|641
Metabolomics Reveals Signature of Mitochondrial Dysfunction in Diabetic Kidney Disease
|Journal of the American Society of Nephrology|2013|578
Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies.
|Diabetes|1999|509
Epidemiology, pathophysiology, diagnosis, and management of intracranial artery dissection
|The Lancet Neurology|2015|464
Metabolic Syndrome in Type 1 Diabetes
|Diabetes Care|2005|428